Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure

Neuroendocrine differentiation (NED) in prostate cancer is a well-recognized phenotypic change by which prostate cancer cells transdifferentiate into neuroendocrine-like (NE-like) cells. NE-like cells lack the expression of androgen receptor and prostate specific antigen, and are resistant to treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chang-Deng, Choo, Richard, Huang, Jiaoti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396194/
https://www.ncbi.nlm.nih.gov/pubmed/25927031
http://dx.doi.org/10.3389/fonc.2015.00090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396194/
https://www.ncbi.nlm.nih.gov/pubmed/25927031
http://dx.doi.org/10.3389/fonc.2015.00090

Ejemplares similares